inspection – Page 249

Excursion trend ignored during material storage – product quality impact case study

Case Study on Product Quality Impact from Ignored Excursion Trends during Material Storage In the highly regulated pharmaceutical industry, maintaining stringent control over material storage conditions is critical for ensuring…

Excursion trend ignored during inspection – product quality impact case study

Case Study: Impact of Ignored Excursion Trends on Product Quality The integrity of pharmaceutical products is paramount, and monitoring conditions in storage areas is a critical component of maintaining quality.…

Temperature excursion not assessed during material storage – CAPA failure explained

Understanding the Implications of Unassessed Temperature Excursions in Material Storage In the regulated pharmaceutical environment, maintaining stringent control over material storage conditions is critical to ensuring product integrity and compliance.…

Expired material issued to production during distribution – CAPA failure explained

Case Study: Addressing Expired Material Issued to Production During Distribution In the pharmaceutical manufacturing sector, maintaining the integrity of materials throughout the production and distribution process is paramount. A serious…

CSV not aligned with actual use during requalification – regulatory deficiency case study

Case Study on CSV Misalignment During Requalification: Lessons Learned from a Regulatory Deficiency In the pharmaceutical industry, the validation of computerized systems is crucial not only for ensuring product quality…

PPQ acceptance criteria changed post hoc during change control – regulatory deficiency case study

Regulatory Deficiency Case Study: Changes to PPQ Acceptance Criteria During Change Control In pharmaceutical manufacturing, maintaining compliance and adherence to established protocols is crucial for product quality and regulatory approval.…

PPQ acceptance criteria changed post hoc during requalification – regulatory deficiency case study

Analysis of Post Hoc Changes to PPQ Acceptance Criteria in Requalification: A Regulatory Case Study In the highly regulated realm of pharmaceutical manufacturing, maintaining compliance with established standards is paramount.…

Validation protocol deviation ignored during change control – CAPA and revalidation failure

Addressing Ignored Validation Protocol Deviations During Change Control: A Comprehensive Case Study In the fast-paced world of pharmaceutical manufacturing, maintaining compliance while ensuring product quality is paramount. This case study…

Inadequate worst-case justification during inspection readiness – regulatory deficiency case study

Case Study on Inadequate Justification for Worst-Case Scenarios During Inspections In a highly regulated pharmaceutical environment, demonstrating full compliance with Good Manufacturing Practices (GMP) is essential for ensuring product quality…

CSV not aligned with actual use during validation lifecycle – regulatory deficiency case study

Case Study: Addressing CSV Misalignment with Actual Use in Validation Lifecycle The pharmaceutical industry is heavily reliant on computer systems for data management, regulatory compliance, and production efficiency. However, a…

Inadequate worst-case justification during validation lifecycle – regulatory deficiency case study

Understanding Inadequate Justification in the Validation Lifecycle: A Case Study on Regulatory Deficiencies In the highly regulated pharmaceutical environment, the validation lifecycle is a critical process which assures product quality…

PPQ acceptance criteria changed post hoc during requalification – CAPA and revalidation failure

Revisiting PPQ Acceptance Criteria Changes During Requalification: A Case Study on CAPA Implementation In the realm of pharmaceutical manufacturing, rigorous adherence to established protocols is crucial to ensure product quality…